ArticleEJNMMI radiopharmacy and chemistry2025
Extending the shelf life of ⁶⁸Ge/⁶⁸Ga generators via preconcentration of [⁶⁸Ga]GaCl₃ for preclinical application.
Article in EJNMMI radiopharmacy and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Highlight selection of radiochemistry and radiopharmacy developments by editorial board.EJNMMI radiopharmacy and chemistry · 2026Review
- Long-term performance evaluation of a novel 3.26 GBqEJNMMI radiopharmacy and chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background⁶⁸Ga-labeled tracers are increasingly important for PET imaging and as companion diagnostics with new therapeutic radiopharmaceuticals. The ⁶⁸Ge/⁶⁸Ga generator is a common source for clinical and preclinical ⁶⁸Ga-tracer production; however, its shelf life and efficiency are critical because of the high cost of generator replacement. This study assessed whether preconcentration of [⁶⁸Ga]GaCl₃ using strong cation exchange (SCX) resin can increase yield, apparent molar activity (AMA) and also extend generator shelf-life for preclinical applications.
resultsA ⁶⁸Ge/⁶⁸Ga generator (1.8 GBq at purchase, 14-18 months old) was used. Direct elution involved elution of [⁶⁸Ga]GaCl₃ in 0.1 M HCl, followed by addition to a DOTA-conjugated affibody in acetate buffer (pH 4.6). Preconcentration involved trapping [⁶⁸Ga]GaCl₃ on a SCX (Chromafix PS-H⁺) cartridge, rinsing, and eluting with 0.12 M HCl in 5 M NaCl (300-500 µL), followed by radiolabeling. Radiolabeling was performed at 75-80 °C for 15 min, the products were purified using a NAP-5 column, and the purity was assessed by high-performance liquid chromatography (HPLC). The SCX cartridge trapping efficiency was > 99%, with a elution efficiency of 95.2 ± 1.2% (n = 8). For direct elution, the decay-corrected radiochemical yield (RCYdc) was 78.7 ± 1.5% (n = 3), the AMA was 5.6 ± 0.4 MBq/nmol, and the radiochemical purity (RCP) was 95.3 ± 0.6%. For preconcentration, RCY
conclusionsThe preconcentration technique doubled the product yield and AMA, and extended the shelf life of the generator by 9-12 months for preclinical applications. Preconcentration of [⁶⁸Ga]GaCl₃ using SCX resin is a robust, cost-effective method for maximizing ⁶⁸Ga recovery and increasing the radiotracer yield and AMA, especially with older generators. This approach extends generator shelf-life, supports sustained preclinical research, and reduces radioactive waste and operational costs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.